Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2001;98:779-782
© 2001 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holcomb, K.
Right arrow Articles by Buhl, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holcomb, K.
Right arrow Articles by Buhl, A.

ORIGINAL RESEARCH

Cone Biopsy and Pathologic Findings at Radical Hysterectomy in Stage I Cervical Carcinoma

Kevin Holcomb, MD, Therese M. Dimaio, MD, Anthony D. Nicastri, MD, Roland P. Matthews, MD, Yi-Chun Lee, MD and Ann Buhl, MD

From the Departments of Obstetrics and Gynecology, and Pathology, Division of Gynecologic Oncology, State University of New York Health Science Center, Brooklyn, New York; and Kings County Hospital, Brooklyn, New York.

Address reprint requests to: Kevin Holcomb, MD, Department of Obstetrics and Gynecology, Beth Israel Medical Center, Petrie Division, First Avenue at 16th Street, New York, NY 10003; E-mail: kholcomb{at}chpnet.org.


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
OBJECTIVE: To examine the association between cone biopsy and pathologic findings at radical hysterectomy in stage I cervical carcinoma.

METHODS: Fifty-four patients diagnosed by cone biopsy with stage I cervical carcinoma and treated with radical hysterectomy comprised the study group. The association between the depth of invasion on conization, lymph-vascular invasion, positive cone margins, positive endocervical curettage (ECC), and the depth of residual invasion in the radical hysterectomy specimen was examined using Pearson r and point biserial correlation. Independent predictors of the depth of residual invasion were determined by multiple regression.

RESULTS: The depth of residual invasion correlated significantly with the depth of invasion (r = .374) and presence of lymph-vascular invasion (rpb = .372) in the conization specimen, post-cone ECC status (rpb = .669), and age at diagnosis (r = .347). The same factors were jointly assessed using multiple regression (R2 = .636, P< .001). Depth of invasion on conization, lymph-vascular invasion, and ECC status were identified as independent predictors of the depth of residual invasion. Patients with deep (5 mm or greater) stromal invasion and lymph-vascular invasion on conization had significantly higher rates of positive parametrial margins (22% compared with zero, P = .001) and adjuvant radiation (66.7% compared with 20%, P = .004) compared with all other patients.

CONCLUSION: Depth of invasion, presence of lymph-vascular invasion, and age at diagnosis were independent predictors of the depth of residual invasion in the subsequent hysterectomy specimen. These factors should be considered in treatment planning. Patients with a combination of these factors may have increased risk for deep residual invasion, positive hysterectomy margins, and adjuvant radiation.

Radical hysterectomy has been used in the treatment of stage I cervical cancer with relative success, providing an 85% chance of 5 year survival.1,2 Unfortunately, there remains a population of patients who will ultimately fail surgical treatment, and the mortality after surgery has remained unchanged over the last three decades.3

Previous studies have identified adverse prognostic indicators for stage I cervical cancer that are independently associated with tumor recurrence and decreased survival. These factors, which are diagnosed at the time of radical hysterectomy and pelvic lymphadenectomy, include pelvic and para-aortic lymph node metastases,4,5 positive surgical margins, and primary tumor-related factors such as deep stromal invasion6 and lymph-vascular space invasion.7

Cervical conization before radical hysterectomy provides an opportunity for a preoperative assessment of tumor invasiveness. This assessment may be helpful in estimating the risk of poor prognostic factors and determining the mode of treatment. The purpose of the current study was to determine if there is a significant correlation between cervical cone biopsy and pathologic findings at radical hysterectomy in patients with stage I cervical cancer.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
All patients diagnosed with stage I cervical carcinoma by cone biopsy that were treated subsequently with radical hysterectomy at State University of New York–Downstate Medical Center and Kings County Hospital between 1984 and 1998 were identified. Pertinent demographic and clinical information was abstracted from the tumor registry and tumor board notes. These data included cervical size, histologic findings of the cone biopsy and hysterectomy specimens, history of adjuvant pelvic radiation, and indication for adjuvant treatment.

All slides of the conization specimens were reviewed by two of the authors (TMD and ADN) with special attention given to the presence of lymph-vascular space invasion, depth of stromal invasion, margin status, and postconization endocervical curettage (ECC) status. The depth of invasion in the conization specimen was recorded in millimeters, whereas the depth of residual invasion was recorded in millimeters and fractional thirds (ie, inner, middle, and outer third stromal invasion). The association between the depth of residual invasion and these cone biopsy factors was examined using Pearson r and point biserial correlation.8 The point biserial correlation (rpb) is equivalent to the Pearson product moment correlation between two variables where one is dichotomous and the other is continuous. A linear regression model was created using cone biopsy measures to determine which factors are predictors of the depth of residual invasion. Additionally, patients with deep stromal invasion (5 mm or greater) and lymph-vascular space invasion on conization were then compared with all other patients, using {chi}2 analysis, with regard to hysterectomy margins, nodal status, and the rate of adjuvant radiation. Statistical Package for the Social Sciences (Chicago, IL) software was used for all statistical analyses.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
During the study period, 83 patients were diagnosed with stage I cervical carcinoma by conization and were subsequently treated with radical hysterectomy and pelvic lymphadenectomy. Fifty-four patients were identified as having adequate clinical information and histologic slides available for review. Demographic and clinical descriptions of the study population are presented in Table 1Go. The mean age was 48.3 years. No patient had a gross cervical lesion and the mean size of the cervix was 3.1 cm (range 1–5 cm). Forty-four squamous cell carcinomas (81.5%), four adenocarcinomas (7.4%), two adenoid basal carcinomas (3.7%), and four tumors of other histologic types (7.4%) were diagnosed.


View this table:
[in this window]
[in a new window]
 
Table 1. Patient Characteristics
 
The mean depth of stromal invasion found in the conization specimens was 4.6 mm (range 1–8 mm). The cone biopsy margins were negative in 12 patients. Ectocervical and endocervical margins were positive in eight and 20 patients, respectively. Both margins were positive in 14 patients. Endocervical curettage was performed after 43 cone biopsies. Twenty-six patients had an ECC that was positive for dysplasia or invasive carcinoma, whereas the ECC was negative in 17 patients. Lymph-vascular space invasion was identified in 13 cone biopsy specimens (24%).

After radical hysterectomy, 19 patients had no residual tumor detected. Inner, middle, and outer third residual stromal invasion was seen in 13 patients, nine patients, and 13 patients, respectively. Lymph-vascular space invasion was detected in 11 (20%) hysterectomy specimens, and the parametrial margins were positive for carcinoma in two patients (3.7%). Three women had positive pelvic nodes (5.6%) and a para-aortic metastasis was found in one patient (2%).

Fifteen patients (27.8%) had poor prognostic indicators diagnosed on radical hysterectomy and received adjuvant pelvic radiation. The indications for adjuvant treatment included a combination of outer third residual stromal invasion and lymph-vascular space invasion (five patients), outer third residual stromal invasion alone (four patients), positive nodes (four patients), and positive surgical margins (two patients).

We examined the association between depth of invasion on conization, presence of lymph-vascular space invasion in the cone specimen, status of the post-cone ECC, age at presentation, and the presence of vaginal spotting at diagnosis with the depth of residual invasion using Pearson r and point biserial correlation. The depth of residual invasion was found to be significantly correlated with depth of invasion (r = .374, P = .005) and presence of lymph-vascular space invasion (rpb = .372, P = .006) in the conization specimen, post-cone ECC status (rpb = .669, P < .001), and age at diagnosis (r = .347, P = .01). The correlation between the depth of residual invasion and the presence of vaginal spotting approached significance (rpb = .262, P = .055).

To examine jointly the association between these factors and the depth of residual invasion we created a linear regression model. The coefficient of determination (R2) was .636 (F5,37 = 12.928, P < .001). The results of the multiple linear regression are presented in Table 2Go. Depth of invasion on conization, presence of lymph-vascular space invasion, and post-cone ECC status were found to be significant predictors of the depth of residual invasion.


View this table:
[in this window]
[in a new window]
 
Table 2. Multiple Linear Regression: Predictors of Residual Invasion at Radical Hysterectomy*
 
The study population was then divided into two groups. Patients with the combination of depth of invasion of 5 mm or greater and lymph-vascular space invasion on conization comprised group 1, whereas all other patients comprised group 2. The percentage of patients in each group with positive parametrial margins, outer third residual stromal invasion, and lymph node metastases were compared using {chi}2 analysis. Parametrial margins were positive in two of nine women (22%) in group 1, whereas all 45 women in group 2 had negative margins ({chi}2 = 10.38, P = .001). Outer third residual stromal invasion was found in six women (66.7%) in group 1 and seven women (15.6%) in group 2 ({chi}2 = 10.72, P = .001). There was a trend toward increased lymph node metastases in group 1 (22%) compared with group 2 (4.4%), however statistical significance was not reached ({chi}2 = 3.46, P = .06). The rates of adjuvant radiation given for the above-stated indications were then compared between the groups. Group 1 had a significantly increased rate of adjuvant radiation (66.7% compared with 20%) compared with group 2 ({chi}2 = 8.14, P = .004). This difference remained statistically significant when cone biopsies with nonsquamous histologies were excluded (47% compared with 16%, P = .02).


    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Our data indicate that the depth of invasion on conization, the presence of lymph-vascular space invasion in the cone specimen, and the status of the post-cone ECC are all independent predictors of the depth of residual invasion in the subsequent radical hysterectomy specimen. These three cone biopsy factors were found to account for 64% of the variance in the depth of residual invasion. This correlation between cone biopsy and radical hysterectomy findings is not only of prognostic significance but may also be helpful in treatment planning when invasive cervical carcinoma is diagnosed by conization.

Based on clinical presentation, the patient population of the current study may be considered at low risk for adverse prognostic indicators and excellent candidates for radical hysterectomy. No patient had a visible cervical lesion and the mean size of the cervix was 3.1 cm. Twenty-eight percent of the patients, however, had poor prognostic factors including positive nodes, positive margins, outer third residual stromal invasion, and a combination of deep residual invasion and lymph-vascular space invasion documented by radical hysterectomy.

Because of the retrospective nature of this review, adjuvant radiation was offered to the study population in a subjective manner. This is a reflection of institutional policy and does not imply that each indication was appropriate. Several authors, however, have recommended adjuvant pelvic radiation after radical hysterectomy in patients with poor prognostic factors such as positive nodes, positive margins, deep stromal invasion, and lymph-vascular space invasion to improve local control.7,9–11 Sedlis et al, in a recent Gynecologic Oncology Group study, documented a 47% reduction in the risk of recurrence in patients receiving adjuvant pelvic radiotherapy for large tumor size, deep stromal invasion, and lymph-vascular space invasion.12

Because of the increased risk of poor prognostic factors seen in patients with deep stromal invasion and lymph-vascular space invasion on conization, 66% of patients with 5 mm or greater stromal invasion and lymph-vascular space invasion received adjuvant radiation after radical hysterectomy, compared with only 20% of all other patients.

Radical hysterectomy and pelvic irradiation have been found to be of equivalent efficacy in the treatment of stage I cervical cancer.13,14 The choice of treatment modality for stage I disease is usually based on the risk of comparative morbidity. Surgery has been preferred in young women because of increased rates of ovarian preservation15 and because many surgeons believe sexual dysfunction is more prevalent after radiation therapy.16 These benefits of radical hysterectomy, however, are not applicable to patients who ultimately receive postoperative radiation. Anderson et al reported only four of 24 (17%) patients who received postoperative radiation maintained ovarian function despite ovarian transposition.15 Alterations in sexual function are also reported to be more pronounced in patients receiving a combination of pelvic surgery and radiation than either radiation or operation alone.17 In addition, the rate of enteric complications after a combined modality approach may be higher than primary irradiation alone. Barter et al documented complications, such as obstruction, fistula, and dysfunction, in 30% of patients treated with radical hysterectomy and pelvic radiation.18 The incidence of major complications from primary irradiation for stage I cervical cancer has been reported to be 3–5%.19

The increased rate of complications observed in patients treated with both radiation and surgery has not been associated with an improvement in clinical outcome. Previous studies have shown no significant difference in tumor control or survival in patients with squamous cell carcinoma treated with a combination of radiation and surgery compared with irradiation alone.20,21 Therefore, the likelihood of adjuvant radiation after radical hysterectomy should be considered when selecting a treatment modality.

Our data indicate that cone biopsy parameters are helpful in estimating the risk of residual stromal invasion, surgical margin status, and possibly lymph node metastases. In our institution, patients with depth of invasion of 5 mm or greater and lymph-vascular space invasion on conization had a significantly increased rate of adjuvant radiation compared with all other patients. Larger studies with standardized indications for adjuvant radiation are necessary to confirm these findings.


    Footnotes
 
The authors thank Mr. Hans Von Gizycki for his contribution to the statistical analysis of this study.

PII S0029-7844(01)01536-8

Received January 31, 2001. Received in revised form June 18, 2001. Accepted June 28, 2001.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
1. Allen HH, Collins JA. Surgical management of carcinoma of the cervix. Am J Obstet Gynecol 1977;127:741–4.[Medline]

2. Artman LE, Hoskins WJ, Bibro MC, Heller PB, Weiser EB, Barnhill DR, et al. Radical hysterectomy and pelvic lymphadenectomy for stage IB carcinoma of the cervix: Twenty-one years’ experience. Gynecol Oncol 1987;28:8–13.[Medline]

3. Patterson F. Annual report on the results of treatment in gynecologic cancer (FIGO). Int J Gynaecol Obstet 1991; 21(Suppl 1):36.

4. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathologic study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 1990;38:352–7.[Medline]

5. Tanaka Y, Sawada S, Murata T. Relationship between lymph node metastases and prognosis in patients irradiated postoperatively for carcinoma of the uterine cervix. Acta Radiol 1984;23:455–9.

6. Boyce J, Fruchter RG, Nicastri AD, Ambiavagar PC, Reinis MS, Nelson JH Jr. Prognostic factors in stage I carcinoma of the cervix. Gynecol Oncol 1981;12:154–65.[Medline]

7. Boyce JG, Fruchter RG, Nicastri AD, DeRegt RH, Ambiavagar PC, Reinis M, et al. Vascular invasion in stage I carcinoma of the cervix. Cancer 1984;53:1175–80.[Medline]

8. Darlington RB, Carlson P. Behavioral statistics. New York: The Free Press, 1987.

9. Chung CK, Nahhas WA, Stryker JA, Curry SL, Abt AS, Mortel R. Analysis of factors contributing to treatment failure in stage IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 1980;138:550–6.[Medline]

10. Abdulhayoglu S, Rich WM, Reynold J, Disaia PJ. Selective radiation therapy in stage IB uterine cervical carcinoma following radical pelvic surgery. Gynecol Oncol 1980;10: 84–92.[Medline]

11. Rotman M, John M, Boyce J. Prognostic factors in cervical carcinoma: Implications in staging and management. Cancer 1981;48:560–7.[Medline]

12. Sedlis A, Bundy B, Rotman M, Lentz S, Muderspach L, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group study. Gynecol Oncol 1999;73:177–83.[Medline]

13. Morely GW, Seski JC. Radical pelvic surgery versus radiation for stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol 1976;126:785–98.[Medline]

14. Newton M. Radical hysterectomy or radiotherapy for stage I cervical cancer. Am J Obstet Gynecol 1975;123:535–42.[Medline]

15. Anderson B, LaPolla J, Turner D, Chapman G, Buller R. Ovarian transposition in cervical cancer. Gynecol Oncol 1993;49:206–14.[Medline]

16. Abitbol MM, Davenport JH. Sexual dysfunction after therapy for cervical carcinoma. Am J Obstet Gynecol 1974;119:181–9.[Medline]

17. Flay LD, Matthews JHL. The effects of radiotherapy and surgery on the sexual function of women treated for cervical cancer. Int J Radiat Oncol Biol Phys 1995;31:399–404.[Medline]

18. Barter JF, Soong SJ, Shingleton HM, Hatch KD, Orr JW Jr. Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol 1989;32:292–6.[Medline]

19. Kottmeier HL. Complications following radiation therapy in carcinoma of the cervix and their treatment. Am J Obstet Gynecol 1964;88:854–61.[Medline]

20. Kilgore LC, Soong SJ, Gore H, Shingleton HM, Hatch KD, Partridge EE. Analysis of prognostic features in adenocarcinoma of the cervix. Gynecol Oncol 1988;31:137–53.[Medline]

21. Grigsby PW, Perez CA, Kuske RR, Camel HM, Kao MS, Galakatos AE, et al. Adenocarcinoma of the uterine-cervix: Lack of evidence for poor prognosis. Radiother Oncol 1988;12:289–96.[Medline]





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holcomb, K.
Right arrow Articles by Buhl, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holcomb, K.
Right arrow Articles by Buhl, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS